(CNN) – A pediatric Oxford-AstraZeneca vaccine case has been dropped in the run-up to a revision by the Reino Unid drug regulator of rare cases of adult blood clots, according to CNN a spokesman for Oxford University on March.
“If there are no security issues in the pediatric clinical trial, we will provide additional information to the [Agencia Reguladora de Medicamentos y Productos Sanitarios] about his revision of rare cases of thrombosis / thrombocytopenia that he has been informed in adults, before administering more vacancies on the site ”, said the spokesman.
“Parents and children should assist in all scheduled visits and be able to communicate with the test sites if they are asked,” he said.
When contacted by CNN, AstraZeneca received our letter from Oxford University.